Ce document numérisé est le fruit d'un long travail approuvé par le ...

46. Chevalier, S., and R. A Roberts. G1-arrested FaO cells re-enter the cell cycle upon
stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin. Careinogenesis 20: 1209­
1213,1999.
47. Chevalier, S., and R. A Roberts. Perturbation of rodent hepatocyte growth control by
nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
Oneol Rep 5: 1319-1327, 1998.
48. Chinetti, G., S. Lestavel, V. Bocher, A T. Remaley, B. Neve, 1. P. Torra, E. Teissier, A
Minnich, M. Jaye, N. Duverger, H. B. Brewer, J. Fruchart, V. Clavey, and B. Staels. PPAR-a and
PPAR-y activators induce cholesterol removal from human macrophage foam cells through stimulation
of the ABCA1 pathway. Nature Med7: 53-58, 2001.
49. Cho, K., J. Oliner, J. Simons, L. Hedrick, E. Fearon, A Preisinger, P. Hedge, G. Silverman,
and B. Vogelstein. The DCC gene: structural analysis and mutations in colorectal carcinomas.
Genomies 19: 525-531, 1994.
50. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidiumthiocyanate-phenol-chloroform
extraction. Anal. Bioehem. 162: 156-159, 1987.
51. Christensen, J. G., A J. Gonzales, R. C. Cattley, and T. L. Goldsworthy. Regulation of
apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth
Oiffer 9: 815-825, 1998.
52. Chu, R., D. Madison, Y. Lin, P. Kopp, M. S. Rao, J. L. Jameson, and J. K. Reddy. Thyroid
hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes :
cross talk between peroxisome proliferator and T3 signaling pathways. Proe Nat! Aead Sei USA 92:
11593-11597, 1995.
53. Claassen, G., and S. Hann. A role for transcriptional repression of p21 CIPI by c-myc in
overcoming transforming growth factor ~ - induced cell cycle arrest. Proe Nat! Aead Sei USA 97: 9498­
9503,2000.
54. Clatworthy, J., and V. Subramanian. Stem ceIls and the regulation of proliferation,
differentiation and patterning in the intestinal epithelium: emerging insights from gene expression
patterns, transgenic and gene ablation studies. Meehanisms Oev 101: 3-9, 2001.
55. Clay, C. E., A M. Namen, G. 1. Atsumi, M. C. Willingham, K. P. High, T. E. Kute, A J. Trimboli,
A N. Fonteh, P. A Dawson, and F. H. Chilton. Influence of J series prostaglandins on apoptosis and
tumorigenesis of breast cancer cells. Careinogenesis 20: 1905-1911, 1999.
56. Committee, N. R. N. A unified nomenclature system for the nuclear receptor family. Cell 97:
161-163,1999.
57. Cormier, R. T., K. Hong, R. Halberg, T. Hawkins, P. Richardson, R. Mulherkar, W. Dove, and
E. Lander. Secretory phospholipase PLA2 confers resistance to intestinal tumorigenesis. Nat Genet
17: 88-91, 1997.
58. Corton, J. C., P. J. Lapinskas, and F. J. Gonzalez. Central role of PPARa in the mechanism of
action of hepatocarcinogenic peroxisome proliferators. Mutation Res. 448: 139-151, 2000.
59. Cummings, J. Short chain fatty acids in the human colon. Gut 22: 763-779, 1981.
60. Cunningham, J., J. Lust, D. Schaid, G. Bren, H. Carpenter, E. Rizza, J. Kovach, and S.
Thibodeau. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992: 1974­
1980,1994.
61. Dauça, M., S. Cable, R. Calvert, S. Colin, J. Schilt, B. Leheup, J. Keller, and D. Menard.
Peroxisomes and peroxisomal enzymes in the human fetal small intestine. Biol Neonate 69: 21-21,
1996.
62. DeArcangelis, A, P. Neuville, R. Boukamel, O. Lefebvre, M. Kedinger, and P. Simon­
Assmann. Inhibition of laminin a-1 chain expression leads to alteration of basement membrane
assembly and cell differentiation. J Cell Biol 133: 417-430, 1996.
63. Delerive, P., F. Martin-Nizard, G. Chinetti, F. Trottein, J. C. Fruchart, J. Najib, P. Duriez, and B.
Staels. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1
production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.
Circ Res 85: 394-402, 1999.
64. DeLomos, C. The ultrastructures of endocrin ceIls in the corpus of the stomach of human
fetuses. Am J Anat 148: 359-384,1977.
65. Demetri, G., C. Fletcher, E. Mueller, P. Sarraf, R. Naujoks, N. Campbell, B. Spiegelman, and
S. Singer. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptorgamma
ligand troglitazone in patients with Iiposarcoma. Proe Nat! Aead Sei USA 96: 3951-3956, 1999.
66. Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. The
PPAR alpha-Ieukotriene B-4 pathway to inflammation control. Nature 384: 39-43, 1996.
113